|
DEVELOPMENT PROCESS 2014年 January 10, Hangzhou TingkeBio Technology Co., Ltd. was established. iTinkerbio received funding from the first batch of "5213" plan key support projects in Xiaoshan District in 2014. The R&D team participated in the sub-project of the national major scientific instrument and equipment development project "Development and Application of Aerospace Medical Body Fluid Research Equipment". In September, the company was recognized as a “Blue Enterprise” in Hangzhou by the Hangzhou Science and Technology Commission In October, TingkeBio received its first round of angel investment 2015~2016年 Successfully developed two major technology platforms: centrifugal microfluidics and pump-valve driven microfluidics. Three series of microfluidic POCT systems for biochemistry, immunity and nucleic acid (fully automatic centrifugal microfluidic biochemical analyzer, centrifugal microfluidic nucleic acid amplification analyzer, handheld microfluidic pesticide residue rapid tester). 2017年 Construction of a batch production line for polymer (PMMA, PC, PP, COC, PS, etc.)microfluidic chips. Establishment of the mass production process for microfluidic chips from mold injection, thermoforming, surface modification, reagent integration, and rapid bonding. In April, TimerBio received the second round of investment. In August, the company was recognized as "Hangzhou High-tech Enterprise". 2018年 In January, the company undertook a major science and technology plan project of Xiaoshan District, "Development of textile quality and safety on-site rapid detection system based on microfluidic chip technology". In December, the company was recognized as "National High-tech Enterprise". 2019~2020年 TinkerBio provides microfluidic chip product design, development, processing and production services to hundreds of universities and companies at home and abroad, becoming a pioneer in microfluidic chip CDMO. 2021年 TinkerBio received the third round of investment. TinkerBio has built a 1,000m² microfluidic chip R&D laboratory and a 2,000 m² microfluidic chip GMP standard production workshop. The R&D team participated in the Zhejiang Provincial Key R&D Program Project "High Sensitivity Rapid Diagnostic Reagents and Equipment R&D", "Covid-19 Nucleic Acid Rapid Detection System". In December, the Company was recognized as a "National High-Tech Enterprise" again after 2018. 2022年 In June, TinkerBio successfully passed the ISO13485:2016 medical device quality management system certification. In June, the TinkerBio textile rapid testing microfluidic chip project was approved by the Fujian Provincial Department of Science and Technology. In December, Tingke Biotechnology was awarded the honorary title of "Hangzhou 2022 Innovative Small and Medium-sized Enterprises". 2023年 TinkerBio completed tens of millions of yuan in Series A+ financing and accelerated the construction of a microfluidic chip production factory. In March, the pesticide residue rapid tester independently developed by Tingke Biotech was selected into the "2022 Hangzhou High-Quality Product Recommended Catalog" In May, TinkerBio was ranked among the "2023 Future Healthcare 100 Main List" and "China's Top 100 Innovative Business and Supply Chain Services List". In May, TinkerBio was recognized as a specialized and innovative small and medium-sized enterprise. iIn May, TinkerBio was recognized as the "Hangzhou TinkerBio Microfluidic Chip Enterprise High-tech Research and Development Center". |